(Reuters) - U.S. health regulators on Thursday approved a blood clot preventer developed by Merck & Co for use by patients who have had a heart attack or who suffer from blockages in the arteries of the legs.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
Lake forest health and fitness http://ift.tt/1itQL5j
No comments:
Post a Comment